Pemetrexed disodium is an organic sodium salt that acts as an antimetabolite and antineoplastic agent. It inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase, enzymes involved in folate metabolism.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 150399-23-8
Pemetrexed disodium heptahydrate
pharmaceutical raw material
Pemetrexed disodium hemipentahydrate
pharmaceutical raw material
Setmelanotide acetate
pharmaceutical raw material
Methyl(nitroso){3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amine
pharmaceutical raw material
Daridorexant
pharmaceutical raw material
Tolvaptan
pharmaceutical raw material
D-Pemetrexed disodium
pharmaceutical raw material
Pemetrexed
active pharmaceutical ingredient
disodium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
NYDXNILOWQXUOF-GXKRWWSZSA-L
C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]